Glossary · GHRH analog
Sermorelin
Also known as: GRF 1-29 · GHRH 1-29
- Class
- GHRH analog
- Half-life
- ~10–20 minutes
- Typical dose
- 100–500 mcg/day, pre-bed
- Route
- subq
Mechanism
Sermorelin is the first 29 amino acids of endogenous GHRH, which is 44 residues long. That truncation preserves the receptor-binding and signaling activity while dramatically shortening half-life — approximately 10–20 minutes after injection. The result is a single clean GH pulse at the moment of administration, with no residual receptor stimulation afterward. The pituitary GHRH receptor returns to its normal state between doses, which is why receptor downregulation risk is lower with sermorelin than with long-acting DAC variants on extended cycles.
Because the pulse is both discrete and tied to endogenous GH secretion patterns, sermorelin sits closest to the physiological axis of all GHRH analogs. Nightly pre-bed dosing aligns with the body's dominant nocturnal GH pulse, amplifying an event that was already going to happen. This is the mechanism behind sermorelin's well-documented sleep quality improvement — deeper sleep stages, improved slow-wave sleep, and the anabolic recovery that follows.
Like all GHRH analogs, sermorelin provides the ceiling-raising function. A paired GHRP (ipamorelin, GHRP-6) triggers the actual pulse and compounds the GH output substantially. Running sermorelin solo at pre-bed produces real results over months; running it with ipamorelin at each dose accelerates those results considerably.
Typical protocol
- Starter: 200 mcg SC pre-bed, nightly, 5 days on / 2 off.
- Advanced: 300 mcg SC pre-bed + 200 mcg SC post-workout, combined with ipamorelin 200 mcg at each dose. Cycle 12–16 weeks on (longer cycles viable than DAC).
- Cycle length: 12–16 weeks on / 4 weeks off (shorter half-life means lower downregulation risk, allowing longer runs than CJC-1295 DAC).
- Reconstitution: 2 mg vial + 2 mL bacteriostatic water → 1 mg/mL. 20 IU on a U-100 insulin syringe = 0.2 mL = 200 mcg.
Who it's for
Longevity users wanting a conservative GH-axis nudge without committing to a week-long half-life. Beginners to GH peptides for whom short-acting and easily reversible is the right starting point. Older lifters chasing sleep quality, gradual recovery improvements, and slow body composition shifts over a full cycle. The nightly pre-bed protocol is sustainable and low-friction.
Stacks well with
- ipamorelin 5mg — clean synergy; both are short-acting, both have minimal cortisol/prolactin impact, making this the most tolerable GHRH+GHRP pairing available.
- ghrp 6 5mg — alternative GHRP when appetite drive is a feature, not a bug (bulking phases).
Watch-outs
- The short half-life means the fasting requirement is non-negotiable. Food — especially carbohydrates — consumed within 2 hours before dosing will blunt somatostatin inhibition and largely eliminate the pulse. Dose strictly on an empty stomach.
- Effects are gradual and subtle. Better sleep quality arrives in the first few weeks; body composition shifts take 2–3 months of consistent use. Don't assess on a 4-week timeline.
- Reconstituted sermorelin should be kept refrigerated and used within 30 days. The short-chain fragment is less stable than longer analogs — degradation means wasted doses, not dangerous doses.
About Sermorelin
What is Sermorelin?
Sermorelin is the first 29 amino acids of endogenous GHRH, which is 44 residues long. That truncation preserves the receptor-binding and signaling activity while dramatically shortening half-life — approximately 10–20 minutes after injection.
What is the half-life of Sermorelin?
Plasma half-life of Sermorelin is reported at ~10–20 minutes. This is a research-reference figure derived from published pharmacokinetic studies — administration timing and dosing intervals in published protocols are designed around this value.
What is the typical research dose range for Sermorelin?
Published research-protocol ranges for Sermorelin fall between 100–500 mcg/day, pre-bed, administered subcutaneously. These figures reference research-literature dosing only — they are not a clinical recommendation and Sermorelin is supplied here strictly as a research reagent.
What class of compound is Sermorelin?
Sermorelin belongs to the GHRH analog class of research peptides. It is also referred to in the literature as GRF 1-29 or GHRH 1-29. Each GHRH analog compound shares overlapping pharmacology but differs in receptor selectivity, half-life, and reported research applications.
What is the typical research-protocol cycle for Sermorelin?
Starter: 200 mcg SC pre-bed, nightly, 5 days on / 2 off. Advanced: 300 mcg SC pre-bed + 200 mcg SC post-workout, combined with ipamorelin 200 mcg at each dose.
Catalog note
Sermorelin is not currently stocked
Sermorelin is a research compound we track in our knowledge base but do not currently carry as an SKU. For sourcing inquiries or bulk institutional orders, contact our team. Meanwhile, browse the full catalog of ≥99% HPLC-verified peptides we do stock.
Same research goal
Related research compounds
Glossary entries describe research pharmacology for in-vitro and laboratory contexts only.







